Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1140 | 1140 | 1241 | 1200 | 1511 | 2249 |
Fund Return | 14.05% | 14.05% | 24.07% | 6.25% | 8.61% | 8.44% |
Place in category | 4224 | 4224 | 1042 | 1134 | 1170 | 650 |
% in Category | 60 | 60 | 17 | 23 | 31 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 9.02B | 18.17 | 9.14 | 13.09 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.49B | 16.91 | 7.54 | 10.23 | ||
UBS CH Vitainvest 50 World U | 4.3B | 2.45 | -0.62 | 2.66 | ||
UBS CH Institutional Fund 2 EquUSAA | 2.17B | 18.12 | 8.92 | 12.85 | ||
UBS CH Institutional Fund 2 EquiSCX | 2.34B | 11.77 | 0.06 | 7.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081620 | 8.36B | 6.72 | 8.43 | - | ||
Swisscanto CH IPF I Index Equity Fu | 6.04B | 10.60 | 8.37 | 9.76 | ||
CH0337393745 | 6.27B | 7.41 | 8.69 | - | ||
UBS CH Institutional Fund 2 EquiPAX | 4.49B | 16.91 | 7.54 | 10.23 | ||
Swisscanto CH IPF III Index EquAST | 3.69B | 10.63 | 7.97 | 9.33 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 4.88 | 401.50 | -1.19% | |
Visa A | US92826C8394 | 2.72 | 271.85 | -0.97% | |
Eli Lilly | US5324571083 | 2.71 | 736.10 | +0.35% | |
Amazon.com | US0231351067 | 2.69 | 180.24 | +0.35% | |
Ameriprise Financial | US03076C1062 | 2.28 | 414.81 | +1.17% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review